Literature DB >> 21895514

Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis.

S J Turner1, A Dharmasena, J Deane.   

Abstract

UNLABELLED: Multiple sclerosis is associated with iridocyclitis, intermediate uveitis, retinal periphlebitis, and optic neuritis. The periphlebitis is known to be rarely sight-threatening as a result of the sequelae of retinal neovascularization. CASE: This is a rare case of bilateral rubeosis iridis and rubeotic glaucoma in the setting of a branch retinal vein occlusion, widespread peripheral periphlebitis, and angiographic peripheral closure associated with "clinically definite" multiple sclerosis. DISCUSSION: The case illustrates the extreme end of the spectrum of peripheral retinal ischemia and neovascularization associated with demyelinating disease, which can present as rubeotic glaucoma. Such patients require a proactive approach to inflammation, neovascularization, and raised intraocular pressure, including systemic immunosuppression, photocoagulation, and augmented trabeculectomy, respectively. As with other causes of peripheral ischemia, a favorable visual outcome can often be achieved using this strategy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895514     DOI: 10.3109/09273948.2011.602500

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  Unusual presentation of a multiple sclerosis case involving central retinal artery occlusion.

Authors:  Alberto Galvez-Ruiz; Sawsan R Nowilaty
Journal:  Saudi J Ophthalmol       Date:  2014-12-11

2.  Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Eef Allegaert; Mohammad Mairaj Siddiquei; Ajmal Ahmad; Priscilla Gikandi; Gert De Hertogh; Ghislain Opdenakker
Journal:  Molecules       Date:  2022-09-14       Impact factor: 4.927

Review 3.  Ischemic retinal vasculitis and its management.

Authors:  Lazha Talat; Sue Lightman; Oren Tomkins-Netzer
Journal:  J Ophthalmol       Date:  2014-04-15       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.